Adial Pharmaceuticals menu
  • Home
  • About
    • About Adial
    • Management Team
    • Board of Directors
  • Pipeline
    • Pipeline Overview
    • AD04
    • Purnovate
  • Newsroom
    • Press Releases
    • Events
    • YouTube Channel
    • Articles
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
      • Press Releases
      • Upcoming Events
      • Past Events
      • Email Alerts
    • Company Info
    • Financial Information
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
    • Stock Data
      • Detailed Quote
      • Stock Charts
      • Historical Data
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact
    • Contact Us
    • Terms of Use
    • Privacy Policy

Management Team

  • William B. Stilley

    Founder and Chief Executive Officer

  • Cary J. Claiborne

    Chief Operating Officer

  • Bankole A. Johnson, D.Sc., M.D.

    Founder and Chief Medical Officer

  • Joseph Truluck

    Chief Financial Officer

  • Jack Reich, Ph.D

    Head of Regulatory

  • Mark H. Peikin, J.D.

    Chief Strategy Officer

  • Alex Lugovoy

    Chief Business Officer

  • John R. Martin, J.D.

    Chief Legal Officer

  • Schuyler Vinzant

    VP Development

  • Catherine Fratila

    Controller

  • Julien Dimastromatteo, Ph.D

    VP Research

  • Robert D. Thompson, Ph.D

    VP Chemistry

adial
news
  • July 20

    Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder

    Continue Reading
  • July 18

    Adial Pharmaceuticals to Announce Topline Results of ONWARD™ Phase 3 Trial for AD04 in Patients With Alcohol Use Disorder

    Continue Reading
  • June 28

    Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley

    Continue Reading
  • June 27

    Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial

    Continue Reading
  • June 14

    Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

    Continue Reading
adial
twitter
Tweets by AdialPharma
adial
youtube
  • video-04

    Adial Overview 2020

    Watch Now
  • video

    Adial Overview

    Watch Now
  • About the growing AUD market and Adial's targeted potential treatment

    Watch Now
  • NBC29: UVA Researchers & Adial looking into using Purnovate in Burn Wound Care

    Watch Now
  • video

    CEO Bill Stilley talks about AD04 on CBS46 Atlanta

    Watch Now
  • Newsy Morning Rush with Bill Stilley discussing AUD & AD04

    Watch Now
Adial Pharmaceuticals
About
  • About Adial
  • Management Team
  • Board of Directors
Pipeline
  • Pipeline Overview
  • AD04
  • Purnovate
Newsroom
  • Press Releases
  • Events
  • YouTube Channel
  • Articles
Investors
  • Overview
  • Analyst Coverage
  • News/Events
  • Company Info
  • Financial Info
  • Stock Data
  • SEC Filings
  • Governance
Contact
  • Contact Us
  • Terms of Use
  • Privacy Policy
Email Alerts
©Adial Pharmaceuticals 2022